TrialDiabetes, obesity & metabolism2021

Efficacy and safety of dulaglutide 3.0 and 4.5 mg in patients aged younger than 65 and 65 years or older: Post hoc analysis of the AWARD-11 trial.

Juan P Frias et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.